Abstract
Obesity is an increasingly prevalent problem in the United States. Obesity, defined as a BMI greater than 30 kg/m2 affects nearly 40 % of adults in the United States today. Obesity has several negative effects on fertility and reproductive physiology. Obesity is associated with increased time to fertility and overall decreased fecundity. In addition, obesity seems to lead to changes to the hypothalamic–pituitary–ovarian (HPO) axis. Obesity is associated with changes in luteinizing hormone and follicle-stimulating hormone levels. Levels of ovarian hormones, such as estradiol and progesterone, are altered in obese women compared to normal controls. Levels of leptin and two adipokines, leptin and adiponectin, are affected by BMI. These hormones can modulate both pituitary and ovarian function. Overall, obesity seems to lead to a state of relative hypogonadotropic hypogonadism. This chapter reviews studies that have examined obesity and the different aspects of the HPO axis.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Wang Y, Beydoun MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6–28.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief No 82. Hyattsville: National Center for Health Statistics; 2012.
Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med. 2012;30:496–506.
Pagán YL et al. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab. 2006;91:1309–16.
Zaadstra BM et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ. 1993;306:484–7.
Fedorcsák P et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod. 2004;19:2523–8.
Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod. 2007;22:414–20.
Van der Steeg JW et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23:324–8.
Polotsky AJ et al. Association of adolescent obesity and lifetime nulliparity—the Study of Women’s Health Across the Nation (SWAN). Fertil Steril. 2010;93:2004–11.
Jacobsen BK, Knutsen SF, Oda K, Fraser GE. Obesity at age 20 and the risk of miscarriages, irregular periods and reported problems of becoming pregnant: the Adventist Health Study-2. Eur J Epidemiol. 2012;27:923–31.
Jain A et al. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab. 2007;92:2468–73.
Bohlke K, Cramer DW, Barbieri RL. Relation of luteinizing hormone levels to body mass index in premenopausal women. Fertil Steril. 1998;69:500–4.
Ecochard R, Marret H, Barbato M, Boehringer H. Gonadotropin and body mass index: high FSH levels in lean, normally cycling women. Obstet Gynecol. 2000;96:8–12.
De Pergola G et al. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women. Obesity (Silver Spring). 2006;14:1954–60.
Santoro N et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women’s Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab. 2004;89:2622–31.
Rochester D et al. Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril. 2009;92:1410–5.
Santoro N et al. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation. J Clin Endocrinol Metab. 2005;90:4836–45.
Weinberg ME et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism. 2006;55:1473–80.
Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause. 2010;17:718–26.
Legro RS et al. Effects of gastric bypass surgery on female reproductive function. J Clin Endocrinol Metab. 2012;97:4540–8.
Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg. 2006;16:1457–63.
Freeman EW et al. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2007;87:101–6.
Gracia CR, Freeman EW, Sammel MD, Lin H, Nelson DB. The relationship between obesity and race on inhibin B during the menopause transition. Menopause. 2005;12:559–66.
Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95:170–5.
Su HI et al. Body size affects measures of ovarian reserve in late reproductive age women. Menopause. 2008;15:857–61.
Budak E et al. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril. 2006;85:1563–81.
Fernández-Fernández R, Tena-Sempere M, Aguilar E, Pinilla L. Ghrelin effects on gonadotropin secretion in male and female rats. Neurosci Lett. 2004;362:103–7.
Caminos JE et al. Expression of ghrelin in the cyclic and pregnant rat ovary. Endocrinology. 2003;144:1594–602.
Evans JJ, Anderson GM. Balancing ovulation and anovulation: integration of the reproductive and energy balance axes by neuropeptides. Hum Reprod Update. 2012;18:313–32.
Michalakis K, Mintziori G, Kaprara A, Tarlatzis BC, Goulis DG. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism. 2013;62:457–78.
Baldelli R, Dieguez C, Casanueva FF. The role of leptin in reproduction: experimental and clinical aspects. Ann Med. 2002;34:5–18.
Magni P et al. Expression of a leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons. Endocrinology. 1999;140:1581–5.
Lebrethon MC, Vandersmissen E, Gérard A, Parent AS, Bourguignon JP. Cocaine and amphetamine-regulated-transcript peptide mediation of leptin stimulatory effect on the rat gonadotropin-releasing hormone pulse generator in vitro. J Neuroendocrinol. 2000;12:383–5.
Moschos S, Chan JL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril. 2002;77:433–44.
Chabrolle C et al. Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril. 2009;92:1988–96.
Gutman G et al. Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity. Fertil Steril. 2009;91:1837–41.
Brichard SM, Delporte ML, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res. 2003;35:337–42.
Yang WS et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815–9.
Tersigni C et al. Adipokines: new emerging roles in fertility and reproduction. Obstet Gynecol Surv. 2011;66:47–63.
Brothers KJ et al. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metab. 2010;12:295–305.
Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009;361:2252–60.
Olshansky SJ et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352:1138–45.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Polotsky, A.J., Doblado, M.A. (2015). Obesity and the HPO Axis. In: Jungheim, E. (eds) Obesity and Fertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2611-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2611-4_2
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2610-7
Online ISBN: 978-1-4939-2611-4
eBook Packages: MedicineMedicine (R0)